Altered Functional Protein Networks in the Prefrontal Cortex and Amygdala of Victims of Suicide
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Probing molecular brain mechanisms related to increased suicide risk is an important issue in biological psychiatry research. Gene expression studies on post mortem brains indicate extensive changes prior to a successful suicide attempt; however, proteomic studies are scarce. Thus, we performed a DIGE proteomic analysis of post mortem tissue samples from the prefrontal cortex and amygdala of suicide victims to identify protein changes and biomarker candidates of suicide. Among our matched spots we found 46 and 16 significant differences in the prefrontal cortex and amygdala, respectively; by using the industry standard t test and 1.3 fold change as cut off for significance. Because of the risk of false discoveries (FDR) in these data, we also made FDR adjustment by calculating the q-values for all the t tests performed and by using 0.06 and 0.4 as alpha thresholds we reduced the number of significant spots to 27 and 9 respectively. From these we identified 59 proteins in the cortex and 11 proteins in the amygdala. These proteins are related to biological functions and structures such as metabolism, the redox system, the cytoskeleton, synaptic function, and proteolysis. Thirteen of these proteins (CBR1, DPYSL2, EFHD2, FKBP4, GFAP, GLUL, HSPA8, NEFL, NEFM, PGAM1, PRDX6, SELENBP1 and VIM,) have already been suggested to be biomarkers of psychiatric disorders at protein or genome level. We also pointed out 9 proteins that changed in both the amygdala and the cortex, and from these, GFAP, INA, NEFL, NEFM and TUBA1 are interacting cytoskeletal proteins that have a functional connection to glutamate, GABA, and serotonin receptors. Moreover, ACTB, CTSD and GFAP displayed opposite changes in the two examined brain structures that might be a suitable characteristic for brain imaging studies. The opposite changes of ACTB, CTSD and GFAP in the two brain structures were validated by western blot analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serotonin transporter genetic variation and the response of the human amygdala.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M. F., & Weinberger, D. R. (2002) · Science · doi:10.1126/science.1071829 · Cited by 2,340
Spatz Widom, C., DuMont, K., & Czaja, S. J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.49 · Cited by 1,059 · cited 1×
“Epigenetic factors, such as DNA methylation, are known to exist in different psychiatric disorders related to high suicide risk [63,64,65].”
BackgroundAffective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878 · cited 1×
“Major depression and bipolar disorder generally increase the incidence of suicide [3].”
BackgroundHypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder
Abdolmaleky, H. M., Cheng, K.-H., Faraone, S. V., Wilcox, M., Glatt, S. J., Gao, F., Smith, C. L., Shafa, R., Aeali, B., Carnevale, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl253 · Cited by 462 · cited 1×
“Epigenetic factors, such as DNA methylation, are known to exist in different psychiatric disorders related to high suicide risk [63,64,65].”
BackgroundAggression, Impulsivity, and Suicide Behavior: A Review of the Literature
Gvion, Y., & Apter, A. (2011) · Archives of Suicide Research · doi:10.1080/13811118.2011.565265 · Cited by 426
Candidate endophenotypes for genetic studies of suicidal behavior
Mann, J. J., Arango, V. A., Avenevoli, S., Brent, D. A., Champagne, F. A., Clayton, P., Currier, D., Dougherty, D. M., Haghighi, F., Hodge, S. E., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.021 · Cited by 398
The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system
Mann, J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00228-1 · Cited by 394
Sequeira, A., Mamdani, F., Ernst, C., Vawter, M. P., Bunney, W. E., Lebel, V., Rehal, S., Klempan, T., Gratton, A., Benkelfat, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006585 · Cited by 388 · cited 5×
“The proteomic changes detected in our study and the results of gene chip studies [9,11,40] show little overlap, which is in agreement with the fact that only a fraction of transcribed genes result in protein expression.”
BackgroundResultInfluentialBernard, R., Kerman, I. A., Thompson, R. C., Jones, E. G., Bunney, W. E., Barchas, J. D., Schatzberg, A. F., Myers, R. M., Akil, H., & Watson, S. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.44 · Cited by 372 · cited 1×
“*+GLUL [69], [90], [102], [109], [110], Glutamate-ammonia ligase, glutamine synthetase qq P15104 Cytoplasm, Golgi apparatus Cell proliferation, glutamine biosynthesis”
BackgroundPoulter, M. O., Du, L., Weaver, I. C. G., Palkovits, M., Faludi, G., Merali, Z., Szyf, M., & Anisman, H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.028 · Cited by 331 · cited 1×
“Unbalanced glutamatergic and GABAergic neurotransmission are also important risk factors in developing suicide behaviour [11,55].”
BackgroundSelf-citationWong, M.-L., Dong, C., Maestre-Mesa, J., & Licinio, J. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.59 · Cited by 295
Klempan, T. A., Sequeira, A., Canetti, L., Lalovic, A., Ernst, C., ffrench-Mullen, J., & Turecki, G. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002110 · Cited by 294 · cited 3×
“These dysfunctions are thought to be major factors in several mental disorders, including major depression [7]; however, the current gene expression data suggest that suicide is possibly correlated with extensive changes in the brain and is not restricted to only one neurotransmitter system [8,9,10].”
BackgroundResultTabarés-Seisdedos, R., & Rubenstein, J. L. R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.2 · Cited by 244 · cited 2×
“Fifteen of the proteins we detected (carbonyl reductase [CBR1], dihydropyrimidinase-like 2 [DPYSL2], EFhand domain family, member D2 [EFHD2], FK506-binding protein 4 [FKBP4], GFAP, GLUL, HSPA8, NEFL, NEFM, phosphoglycerate mutase 1 [PGAM1], PRDX6, SELENBP1, VIM, 14-3-3 protein eta [YWHAH] and 14-3-3 protein zeta/delta…”
BackgroundMethodPennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227 · cited 3×
“*+SEPT5 [119], [122] Septin 5 qq Q99648 Plasma membrane, septin complex, synaptic vesicle Cell cycle, regulation of exocytosis”
BackgroundGlial and glutamatergic markers in depression, alcoholism, and their comorbidity
Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., & Stockmeier, C. A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.06.003 · Cited by 218 · cited 1×
“S *+GFAP [86], [88], [69], [101], [119], [13], [132], [133], [134], Glial fibrillary acidic protein isoform 1 qQQQQ QQQQQ P14136 Cytoplasm, intermedier filament Central nervous system development, structural constituent of cytoskeleton”
BackgroundAntioxidative enzymes and increased oxidative stress in depressive women
Kodydková, J., Vávrová, L., Zeman, M., Jirák, R., Macášek, J., Staňková, B., Tvrzická, E., & Žák, A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.006 · Cited by 197 · cited 1×
“*+GPX1 [129], [130] Glutathione peroxidase Q P07203 Cytosol, mitochondrion UV-protection, anti-apoptosis, cell redox homeostasis, glutathione metabolism, oxidation reduction, hydrogen peroxide catabolism, regulation of caspase activity”
BackgroundTatro, E. T., Everall, I. P., Kaul, M., & Achim, C. L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.036 · Cited by 125 · cited 1×
“+FKBP4 [115], [71] FK506-binding protein 4, 59kDa q Q02790 Cytoplasm, nucleus Protein binding, HSP binding, FK506 binding, peptidyl-prolyl cis-trans isomerase activity”
Monoranu, C. M., Apfelbacher, M., Grünblatt, E., Puppe, B., Alafuzoff, I., Ferrer, I., Al‐Saraj, S., Keyvani, K., Schmitt, A., Falkai, P., et al. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01003a.x · Cited by 121
Dwivedi, Y., Rizavi, H. S., Zhang, H., Roberts, R. C., Conley, R. R., & Pandey, G. N. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990575 · Cited by 101
HNRC, Tatro, E. T., Everall, I. P., Masliah, E., Hult, B. J., Lucero, G., Chana, G., Soontornniyomkij, V., & Achim, C. L. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9146-6 · Cited by 75 · cited 2×
“Fifteen of the proteins we detected (carbonyl reductase [CBR1], dihydropyrimidinase-like 2 [DPYSL2], EFhand domain family, member D2 [EFHD2], FK506-binding protein 4 [FKBP4], GFAP, GLUL, HSPA8, NEFL, NEFM, phosphoglycerate mutase 1 [PGAM1], PRDX6, SELENBP1, VIM, 14-3-3 protein eta [YWHAH] and 14-3-3 protein zeta/delta…”
MethodProteomic analysis of rat hippocampus exposed to the antidepressant paroxetine
McHugh, P., Rogers, G., Glubb, D., Joyce, P., & Kennedy, M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109102786 · Cited by 25 · cited 1×
“*+PRDX6 [68], [131] Peroxiredoxin 6 Q P30041 Cytoplasm, lysosome, cytoplasmic vesicle, nucleus Cell redox homeostasis, oxidation reduction, phospholipid catabolism”
Background
Cited by
Cobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.044 · Cited by 254
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222
Discovery and validation of blood biomarkers for suicidality
Le-Niculescu, H., Levey, D. F., Ayalew, M., Palmer, L., Gavrin, L. M., Jain, N., Winiger, E., Bhosrekar, S., Shankar, G., Radel, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.95 · Cited by 193
Torres-Platas, S. G., Nagy, C., Wakid, M., Turecki, G., & Mechawar, N. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.65 · Cited by 148
Kang, S.-G., Na, K.-S., Choi, J.-W., Kim, J.-H., Son, Y.-D., & Lee, Y. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.029 · Cited by 110
“A proteomic study conducted on post mortem brains of suicide victims to identify protein changes and functional networks found nine proteins that changed in both the amygdala and the prefrontal cortex, and suggested that these two brain areas might be suitable for functional neuroimaging studies on suicide (Kekesi et…”
Background
Metadata
- Authors
- Kékesi, K. A., Juhász, G., Simor, A., Gulyássy, P., Szegő, É. M., Hunyadi-Gulyás, É., Darula, Z., Medzihradszky, K. F., Palkovits, M., Penke, B., & Czurkó, A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-06
- Volume
- 7
- Issue
- 12
- Pages
- e50532
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2039074671
- Cited by
- 72
- References
- 21
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.